論文・総説 - 吉田　雅幸

分割表示  252 件中 121 - 140 件目  ／  全件表示 >>

  1. Ishii H, Tsukada T, Yoshida M. Angiotensin II type-I receptor blocker, candesartan, improves brachial-ankle pulse wave velocity independent of its blood pressure lowering effects in type 2 diabetes patients. Intern Med. 2008; 47 (23): 2013-2018. ( PubMed )

  2. Kojima C, Kawakami A, Takei T, Nitta K, Yoshida M. Angiotensin-converting enzyme inhibitor attenuates monocyte adhesion to vascular endothelium through modulation of intracellular zinc. J Pharmacol Exp Ther. 2007.12; 323 (3): 855-860. ( PubMed, DOI )

  3. Deushi M, Nomura M, Kawakami A, Haraguchi M, Ito M, Okazaki M, Ishii H, Yoshida M. Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome. FEBS Lett. 2007.12; 581 (29): 5664-5670. ( PubMed, DOI )

  4. Mori D, Ishii H, Kojima C, Nitta N, Nakajima K, Yoshida M. Cilostazol inhibits monocytic cell adhesion to vascular endothelium via upregulation of cAMP. J Atheroscler Thromb. 2007.10; 14 (5): 213-218. ( PubMed )

  5. Tani M, Kawakami A, Nagai M, Shimokado K, Kondo K, Yoshida M. Sphingosine 1-phosphate (S1P) inhibits monocyte-endothelial cell interaction by regulating of RhoA activity. FEBS Lett. 2007.10; 581 (24): 4621-4626. ( PubMed, DOI )

  6. Tanaka Y, Ishii H, Hiraoka M, Miyasaka N, Kuroiwa T, Hajjar KA, Nagaoka T, Duong TQ, Ohno K, Yoshida M. Efficacy of recombinant annexin 2 for fibrinolytic therapy in a rat embolic stroke model: a magnetic resonance imaging study. Brain Res. 2007.08; 1165 135-143. ( PubMed, DOI )

  7. Takano Y, Shimokado K, Hata Y, Yoshida M. HIV envelope protein gp120-triggered CD4+ T-cell adhesion to vascular endothelium is regulated via CD4 and CXCR4 receptors. Biochim Biophys Acta. 2007.05; 1772 (5): 549-555. ( PubMed, DOI )

  8. Osaka M, Hagita S, Haraguchi M, Kajimura M, Suematsu M, Yoshida M. Real-time imaging of mechanically injured femoral artery in mice reveals a biphasic pattern of leukocyte accumulation. Am J Physiol Heart Circ Physiol. 2007.04; 292 (4): H1876-82. ( PubMed, DOI )

  9. Nishiwaki Y, Yoshida M, Iwaguro H, Masuda H, Nitta N, Asahara T, Isobe M. Endothelial E-selectin potentiates neovascularization via endothelial progenitor cell-dependent and -independent mechanisms. Arterioscler Thromb Vasc Biol. 2007.03; 27 (3): 512-518. ( PubMed, DOI )

  10. Ishii H, Hiraoka M, Tanaka A, Shimokado K, Yoshida M. Recombinant annexin-2 inhibits the progress of diabetic nephropathy in a diabetic mouse model via recovery of hypercoagulability. Thromb Haemost. 2007.01; 97 (1): 124-128. ( PubMed )

  11. Takahashi K, Shimokado K, Yoshida M. SDF-1-induced adhesion of monocytes to vascular endothelium is modulated by azelnidipine via protein kinase C inhibition. Eur J Pharmacol. 2006.12; 552 (1-3): 162-169. ( PubMed, DOI )

  12. Takei T, Hiraoka M, Nitta K, Uchida K, Deushi M, Yu T, Nitta N, Tsuchiya K, Yumura W, Nihei H, Nakamura Y, Yoshida M. Functional impact of IgA nephropathy-associated selectin gene haplotype on leukocyte-endothelial interaction. Immunogenetics. 2006.06; 58 (5-6): 355-361. ( PubMed, DOI )

  13. Kasuya N, Kishi Y, Isobe M, Yoshida M, Numano F. P-selectin expression, but not GPIIb/IIIa activation, is enhanced in the inflammatory stage of Takayasu's arteritis. Circ J. 2006.05; 70 (5): 600-604. ( PubMed )

  14. Imada T, Tatsumi T, Mori Y, Nishiue T, Yoshida M, Masaki H, Okigaki M, Kojima H, Nozawa Y, Nishiwaki Y, Nitta N, Iwasaka T, Matsubara H. Targeted delivery of bone marrow mononuclear cells by ultrasound destruction of microbubbles induces both angiogenesis and arteriogenesis response. Arterioscler Thromb Vasc Biol. 2005.10; 25 (10): 2128-2134. ( PubMed, DOI )

  15. Gotoh R, Suzuki J, Kosuge H, Kakuta T, Sakamoto S, Yoshida M, Isobe M. E-selectin blockade decreases adventitial inflammation and attenuates intimal hyperplasia in rat carotid arteries after balloon injury. Arterioscler Thromb Vasc Biol. 2004.11; 24 (11): 2063-2068. ( PubMed, DOI )

  16. Hiraoka M, Nitta N, Nagai M, Shimokado K, Yoshida M. MCP-1-induced enhancement of THP-1 adhesion to vascular endothelium was modulated by HMG-CoA reductase inhibitor through RhoA GTPase-, but not ERK1/2-dependent pathway. Life Sci. 2004.07; 75 (11): 1333-1341. ( PubMed, DOI )

  17. Onai Y, Suzuki J, Nishiwaki Y, Gotoh R, Berens K, Dixon R, Yoshida M, Ito H, Isobe M. Blockade of cell adhesion by a small molecule selectin antagonist attenuates myocardial ischemia/reperfusion injury. Eur J Pharmacol. 2003.11; 481 (2-3): 217-225. ( PubMed )

  18. Fujiyama S, Amano K, Uehira K, Yoshida M, Nishiwaki Y, Nozawa Y, Jin D, Takai S, Miyazaki M, Egashira K, Imada T, Iwasaka T, Matsubara H. Bone marrow monocyte lineage cells adhere on injured endothelium in a monocyte chemoattractant protein-1-dependent manner and accelerate reendothelialization as endothelial progenitor cells. Circ Res. 2003.11; 93 (10): 980-989. ( PubMed, DOI )

  19. Toriumi Y, Hiraoka M, Watanabe M, Yoshida M. Pioglitazone reduces monocyte adhesion to vascular endothelium under flow by modulating RhoA GTPase and focal adhesion kinase. FEBS Lett. 2003.10; 553 (3): 419-422. ( PubMed )

  20. Nishiwaki Y, Yokota T, Hiraoka M, Miyagishi M, Taira K, Isobe M, Mizusawa H, Yoshida M. Introduction of short interfering RNA to silence endogenous E-selectin in vascular endothelium leads to successful inhibition of leukocyte adhesion. Biochem Biophys Res Commun. 2003.10; 310 (4): 1062-1066. ( PubMed )

< 前のページ - 次のページ >

このページの先頭へ▲